Clinical trial registration, reporting, publication and FDAAA compliance: a cross-sectional analysis and ranking of new drugs approved by the FDA in 2012-Reference-Cited by-同舟云学术

Clinical trial registration, reporting, publication and FDAAA compliance: a cross-sectional analysis and ranking of new drugs approved by the FDA in 2012

Published:2015-11 Issue:11 Volume:5 Page:e009758
ISSN:2044-6055
Container-title:BMJ Open
language:en
Short-container-title:BMJ Open

Author:

Miller Jennifer E,Korn David,Ross Joseph S

Publisher

BMJ

Subject

General Medicine

Reference24 articles.

1. Non-publication of large randomized clinical trials: cross sectional analysis;Jones;BMJ,2013

2. Trial registration and declaration of registration by authors of randomized controlled trials;McGee;Transplantation,2011

3. Lack of transparency of clinical trial endometriosis;Guo;Obstet Gynecol,2013

4. Publication of clinical trials supporting successful new drug applications: a literature analysis;Lee;PLoS Med,2008

5. Trial publication after registration in ClinicalTrials.Gov: a cross-sectional analysis;Ross;PLoS Med,2009

Cited by 78 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Drug Promotions Between Ethics, Regulations, and Financial Interests;American Journal of Therapeutics;2024-05

2. Changes to Registered and Pivotal Clinical Trials after the 2011 Tri-Societies Guidelines for Clinical Endpoints and Response Criteria in Mycosis Fungoides and Sézary Syndrome;Journal of Investigative Dermatology;2023-11

3. The relationship between study findings and publication outcome in anesthesia research following implementation of mandatory trial registration: A systematic review of publication bias;PLOS ONE;2023-05-26

4. Choices and Challenges With Drug Therapy in Postural Orthostatic Tachycardia Syndrome: A Systematic Review;Cureus;2023-05-11

5. Ranking pharmaceutical companies on clinical trial diversity;BMJ;2023-02-10